VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HIPO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HIPOHippo Holdings Inc.
$34.89$908M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksHIPOCash Flow

Hippo Holdings Inc. (HIPO) Cash Flow Statement

7Y historyFree accessUpdated daily

Operating cash flow improved from a $35.6M outflow in 2025Q1 to $72.6M in 2026Q3, though 2026Q1 operating cash of only $8.5M against $82.4M of claims payments suggests this conversion may depend heavily on quarterly timing.

Income StatementBalance SheetCash FlowRatios

HIPO Cash Flow Statement

Annual statement

HIPO Cash Flow Statement

Hippo Holdings Inc. (HIPO) cash flow statement — 7-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Cash from Operations127.4M9.2M47.5M-92.4M-161.5M-124.5M-65.4M-29.1M
Operating CF Growth %677.96%-80.63%151.41%42.79%-29.72%-90.37%-124.74%-
Operating CF / Revenue %23.48%1.96%12.77%-44.06%-134.92%-136.51%-126.74%-83.86%
Net Income32M57.7M-28.6M-273.1M-326.5M-367.9M-141.4M-83.1M
Depreciation & Amortization14.4M20.4M23.2M19.8M15.2M11M6.7M2.9M
Stock-Based Compensation6.7M29.3M38.2M57.5M61.9M24.3M17.2M21.9M
Deferred Taxes00000000
Other Non-Cash Items226.3M-94M-55.6M10.1M50.6M164.4M27.1M2.8M
Working Capital Changes-126M-4.2M70.3M93.3M37.3M43.7M25M26.4M
Cash from Investing-77.2M-11.2M30.3M57.6M-405.9M-30M-2.3M-72.3M
Capital Expenditures-7.3M-100K-300K-29.6M-19.7M-800K-400K-900K
Acquisitions00000-600K-83.7M-600K
Purchase of Investments-310.3M-287.6M-367.8M-409.6M-793M-26.2M-16.7M0
Sale/Maturity of Investments362.5M307.8M336.9M517.1M408.8M16.5M107.5M0
Other Investing-122.1M-31.3M61.5M-20.3M-2M-18.9M-9M-70.8M
Cash from Financing4.4M19.3M-40.1M-14.6M-6.8M480.8M518.1M101.4M
Dividends Paid00000000
Share Repurchases0-14.5M-15.6M-1.8M0000
Stock Issued3.5M3.8M6.7M2.8M4.1M34.5M00
Debt Issuance (Net)01000K00001000K0
Other Financing900K-17.9M-31.2M-15.6M-10.9M480.8M-1.5M101.4M
Net Change in Cash54.6M17.3M37.7M-49.4M-574.2M326.3M450.4M42M
Exchange Rate Effect00000000
Cash at Beginning271.6M232.8M195.1M244.5M818.7M492.4M42M0
Cash at End326.8M250.1M232.8M195.1M244.5M818.7M492.4M42M
Free Cash Flow120.1M9.1M47.2M-139.1M-181.2M-141.9M-74.8M-30M
FCF Growth %1564.63%-80.72%133.93%23.23%-27.7%-89.71%-149.33%-
FCF Margin %22.13%1.94%12.68%-66.33%-151.38%-155.59%-144.96%-86.46%
FCF per Share4.440.351.91-5.9-7.97-9.17-21.52-61.92

Key Metrics

Growth RegimeExpanding
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Reinsurance cost hardening

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Operating Cash Turns Positive Recently

Based on Hippo's reported figures, operating cash flow improved from a $35.6M outflow in 2025Q1 to $72.6M in 2026Q3, suggesting premium collections are now outpacing claims payments and generating meaningful float.

The swing from sustained negative operating cash flow through 2024 and early 2025 to consistently positive readings in 2026 points to a shift in the underwriting engine rather than a timing artifact alone. Quarterly claims and loss payments of $59.8M to $82.4M in 2026 remain substantial relative to operating inflows, so the margin of float generation is still thin and sensitive to quarter-to-quarter loss timing. Investors should monitor whether operating cash generation holds through a full catastrophe season before treating the improvement as structural.

Portfolio Liquidation Funds Investment Redeployment

As reported in financial statements, Hippo's investment sales of $113.4M in 2026Q2 and $115.4M in 2026Q1 substantially exceeded purchases in the same periods, indicating the portfolio is being drawn down to fund claims and operations.

Consistent net sales of investments in most recent quarters, with purchases of $42.7M to $94.7M against sales of $29.5M to $115.4M, suggests the company is liquidating holdings rather than compounding its portfolio. This pattern may reflect the need to cover claims outflows that exceed operating cash generation in certain quarters. Warrants further investigation into whether portfolio yields and duration are being maintained as balances shrink.

Claims Payouts Remain Elevated Versus Operating Inflows

Based on Hippo's reported figures, claims and loss payments reached $126.7M in 2024Q4 and remained between $45.5M and $82.4M across 2025 and 2026, keeping payout pressure a persistent drag on cash conversion.

Claims paid frequently consume a large share of gross operating inflows, which limits the cash cushion available to absorb a severe catastrophe event. The compression of payouts from the 2024 peak is encouraging but the 2026 run-rate still sits near or above operating cash generation in several quarters. Investors should watch the paid-to-incurred relationship and any reserve development that could shift future payment obligations.

Earnings Volatility Diverges From Cash Generation

According to reported quarterly figures, net income ranged from a $47.7M loss in 2025Q1 to a $98.1M gain in 2025Q3, while operating cash flow stayed far more contained, suggesting earnings are heavily influenced by non-cash accruals.

The wide gap between reported net income swings and operating cash flow indicates that reserve adjustments and accrual timing are driving much of the reported earnings volatility. Operating cash to net income ratios ranging from negative values to 19.00x confirm that quarterly earnings are a poor proxy for cash generation. Investors should rely on multi-quarter cash trends rather than any single period's reported profit.

No Shareholder Distributions Under Current Capital Needs

Based on the reported cash flow data, Hippo paid no dividends across all ten quarters, with only minor buybacks of $14.5M and $15.6M in 2025Q3 and 2024Q4, indicating capital is being retained.

The absence of dividends and the limited buybacks reflect a company still prioritizing balance sheet capacity over shareholder returns. Given recent operating cash volatility and reliance on portfolio liquidation to fund claims, retaining capital appears prudent. Any future shift toward capital return would need to be supported by sustained positive operating cash flow rather than portfolio drawdowns.

Float Strength May Be Overstated Here

As reported in financial statements, operating cash flow in 2026Q1 was only $8.5M against $82.4M of claims and loss payments, suggesting the recent positive cash trend may depend heavily on quarterly timing rather than durable underwriting float.

The most recent positive operating cash readings coexist with portfolio sales that exceeded purchases by a wide margin, so part of the liquidity position may reflect asset liquidation instead of premium-driven cash generation. Several 2026 quarters show claims outflows that approach or exceed operating inflows, which warrants further investigation into whether catastrophe seasonality could reverse the improvement quickly. Investors should monitor whether operating cash remains positive after a full cycle of claims payments and whether reinsurance cost increases compress the float retained from future premium growth.

HIPO — Frequently Asked Questions

Quick answers to the most common questions about buying HIPO stock.

How much cash does Hippo Holdings Inc. (HIPO) generate from operations?

Hippo Holdings Inc. (HIPO) generated $9.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Hippo Holdings Inc.'s free cash flow?

Hippo Holdings Inc. (HIPO) generated $9.1M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Hippo Holdings Inc.'s capital expenditure (CapEx)?

Hippo Holdings Inc. (HIPO) spent $0.1M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Hippo Holdings Inc. distribute cash to shareholders?

In 2025, Hippo Holdings Inc. (HIPO) spent $14.5M on share repurchases. This shows the company's commitment to returning capital to its equity investors.